CA2425767A1 - Lipocalines - Google Patents

Lipocalines Download PDF

Info

Publication number
CA2425767A1
CA2425767A1 CA002425767A CA2425767A CA2425767A1 CA 2425767 A1 CA2425767 A1 CA 2425767A1 CA 002425767 A CA002425767 A CA 002425767A CA 2425767 A CA2425767 A CA 2425767A CA 2425767 A1 CA2425767 A1 CA 2425767A1
Authority
CA
Canada
Prior art keywords
polynucleotide
polypeptide
lipoc
antibody
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002425767A
Other languages
English (en)
Inventor
Preeti G. Lal
Narinder K. Walia
Ameena R. Gandhi
Yan Lu
Jayalaxmi Ramkumar
Mariah R. Baughn
Christopher M. Bruns
April J. A. Hafalia
Monique G. Yao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of CA2425767A1 publication Critical patent/CA2425767A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des lipocalines (LIPOC) humaines et des polynucléotides identifiant et codant pour les lipocalines (LIPOC). L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes, et des antagonistes. L'invention concerne également des méthodes de diagnostic, de traitement, ou de prévention des troubles associés à l'expression aberrante des lipocalines (LIPOC).
CA002425767A 2000-10-13 2001-10-12 Lipocalines Abandoned CA2425767A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24054100P 2000-10-13 2000-10-13
US60/240,541 2000-10-13
PCT/US2001/031942 WO2002031151A2 (fr) 2000-10-13 2001-10-12 Lipocalines

Publications (1)

Publication Number Publication Date
CA2425767A1 true CA2425767A1 (fr) 2002-04-18

Family

ID=22906956

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002425767A Abandoned CA2425767A1 (fr) 2000-10-13 2001-10-12 Lipocalines

Country Status (5)

Country Link
EP (1) EP1325128A2 (fr)
JP (1) JP2004528813A (fr)
AU (1) AU2001296831A1 (fr)
CA (1) CA2425767A1 (fr)
WO (1) WO2002031151A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0217402D0 (en) * 2002-07-26 2002-09-04 Roslin Inst Edinburgh Multi-reporter gene model for toxicological screening
GB0426650D0 (en) * 2004-12-03 2005-01-05 Univ Cardiff Transgenic animals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8899298A (en) * 1997-08-06 1999-03-01 Zymogenetics Inc. Lipocalin homologs
AU2001285183A1 (en) * 2000-08-31 2002-03-13 Zymogenetics Inc. Human phermone polypeptides

Also Published As

Publication number Publication date
WO2002031151A2 (fr) 2002-04-18
AU2001296831A1 (en) 2002-04-22
WO2002031151A3 (fr) 2003-03-06
EP1325128A2 (fr) 2003-07-09
JP2004528813A (ja) 2004-09-24

Similar Documents

Publication Publication Date Title
US20040048290A1 (en) Aminoacyl trna synthetases
US20040018505A1 (en) Aminoacyl trna synthetases
CA2431493A1 (fr) Aminoacyl arnt synthetases
CA2408315A1 (fr) Aminoacyl-arnt synthetases
US20050227277A1 (en) Apoptosis proteins
EP1179065A2 (fr) Molecules completes exprimees dans des tissus humains
US20050048479A1 (en) Adenylyl and guanylyl cyclases
US20020160950A1 (en) Cytochrome P450 variant
EP1190050A2 (fr) Proteines de regulateur de transcription humaines
EP1299546A2 (fr) Aminoacyl arnt synthetases
WO2002048362A2 (fr) Proteines associees a l'embryogenese
CA2425767A1 (fr) Lipocalines
WO2002046413A2 (fr) Molecules pour la detection et le traitement de maladies
US20040043452A1 (en) Embryogenesis associated proteins
CA2378989A1 (fr) Proteines humaines de domaine lim
CA2402747A1 (fr) Molecules associees a la proteine g
US20040033583A1 (en) Isomerases
US20040101872A1 (en) Lipocalins
EP1192250A2 (fr) Proteines du metabolisme de l'arn
WO2001068696A1 (fr) Proteines de reponse immunitaire humaines
EP1477564A2 (fr) Synthetases humaines
US20040096858A1 (en) Adenylyl and guanylyl cyclases
US20040023251A1 (en) Cell cycle proteins and mitosis-associated molecules
US20030208040A1 (en) G-protein associated molecules
CA2417676A1 (fr) Sequences pour l'integrine alpha-8

Legal Events

Date Code Title Description
FZDE Dead